INTRODUCTION
Autogenous arteriovenous fistula (AVF) has been recommended more than other hemodialysis access using artificial graft. The cost of maintaining autogenous AVF is less expensive than artificial access because of lower surgical morbidity, mortality, incidence of infection and good patency rate [1] . However, when autogeneous AVF was occluded by thrombosis, the salvaging procedures for revascularization didn't show satisfactory results. The National Kidney Foundation Dialysis Outcomes Quality Initiatives suggests that choosing the method of salvage procedure depends on the ability of each institution [2] .
To improve the technical success rates of thrombosed thesurgery.or.kr The radiologic image records were reviewed to identify the location of vascular stenosis in each patient. The patients' demographics including types of vascular access, age of AVFs, length of time between thrombosis and salvage procedure, operating time, technical success rates and procedure related complications were collected.
METHODS

Study design
Technical success rate was defined as the successful restoration of AVF flow with uneventful dialysis after the procedure. Primary patency was calculated from the date of the initial salvage procedure to the next subsequent access intervention. Under the circumstance where the majority of patients were referred from other dialysis centers and referred back after successful treatment, patency rate was estimated by telephone survey and patency was confirmed by successful dialysis. Fistula follow-up was censored for patient death, transplant, and change of dialysis modality. This single center retrospective study has been approved by the Institutional Review Board.
Hybrid surgery
All procedures were performed under the local anesthesia. An approximately 2 to 3 cm transverse skin incision was made over non-punctured fistulated vein. The vein was dissected from the surrounding tissue and con- Values are presented as mean ± SD or number (%). AVF, arteriovenous fistula.
OEC 9900 Elite; C-arm fluoroscopy (GE OEC Medical Systems Inc., Salt Lake City, UT, USA).
Percutaneous mechanical thrombectomy
During the percutaneous mechanical thrombectomy, 
Statistics
Patients treated with hybrid surgery and percutaneous mechanical thrombectomy were compared using Student's Stenosis that was believed to be the primary cause of fistula failure.
RESULTS
Overall characteristics of patients
The clinical characteristics of the patients treated with hybrid surgery and those treated with percutaneous mechanical thrombectomy were compared in Table 1 
Angiographic findings and procedure-related outcomes
All the thrombosed autogenous AVFs were found to have a stenosis that was believed to be the primary cause of fistula failure ( Table 2 In the group of patients treated with hybrid surgery, the primary lesions were treated with mainly balloon angioplasty followed by surgical thrombectomy. However, 11 of 40 AVFs (27.5%) in the hybrid surgery group, required additional surgical angioplasties, such as anastomosis revision (n = 7), patching (n = 2), interposition grafting (n = 1), or curettage for intraluminal old fibrous thrombus (n = 1).
In the percutaneous mechanical thrombectomy group, all of the lesions were treated with balloon angioplasty, with two patients undergoing adjunctive stent placement for the recoiling central venous stenosis.
Procedure time was similar between the groups (108.1 ± 47.9 min. vs. 115.6 ± 63.5 min., P = 0.624, respectively).
Technical success rates were higher in the hybrid surgery group than that in the percutaneous mechanical thrombectomy group (92.5% vs. 68.4%, P = 0.005, respectively).
The rescued AVF could be used immediately after the operation or on the next day.
There were three technical failures in the hybrid surgery group. Two were caused by complete occlusion of central venous outflow, which prevented the guide wire passing through it. One failure was caused by tight stricture near the cephalic arch resistant to balloon angioplasty. In the percutaneous mechanical thrombectomy group, the cause of failure included incomplete thrombectomy; the remaining thrombus was shown in the angiography (n = 4, 66.7%), and the inability to pass a guide wire through stenotic lesions (n = 2, 33.3%). In either group, there were no procedure-related complications that required additional treatment. Bleedings caused by vessel tearing during balloon angioplasty, were successfully controlled by balloon tamponade and/or external compression in both groups.
The percutaneous mechanical thrombectomy group showed a tendency for longer hospital stay but was not statistically significant (1.0 ± 2.0 days vs. 2.3 ± 2.9 days, P = 0.058, respectively). 
DISCUSSION
The aim of this study is to compare the outcomes of two patient groups with thrombosed autogenous AVF treated with hybrid surgery and percutaneous mechanical throm-
bectomy.
An increasing number of patients with renal failure are requiring long-term dialysis for 5 to 10 years or even longer. If the clotted vascular access is routinely abandoned, there will be a large number of patients in most dialysis populations who will exhaust the more desirable upper extremity access sites and require alternate sites such as the leg or chest wall. In some patients, all available sites may eventually be used, prohibiting further hemodialysis. Therefore, salvage of thrombosed vascular access is also important due to the limited resources of blood vessels available for the creation of new access and the sparing hemodialysis catheter needed during access maturation [3] .
Most clotted AVFs have one or more underlying stenotic lesions, a complete thrombectomy in conjunction with angioplasty of the stenotic lesions should be required to thesurgery.or.kr successfully treat the AVF thrombosis and to save the previous dialysis access site [4] .
Traditionally, the treatment of thrombosed AVFs consisted of surgical thrombectomy followed by local revision of the access. It is often difficult to completely remove the thrombus adjacent to an anastomosis of the fistula and an aneurysm within the fistula, which can prevent it from passing the thrombectomy catheter. Therefore, surgical thrombectomy of autogenous AVFs is often thought to be a challenging and fruitless endeavor. Although Jain et al. [9] have reported improved technical success rates of percutaneous mechanical thrombectomy (76.0%) for thrombosed autogenous AVFs recently, primary fistula patency was fairly short-lived, and the fistula required repeated interventions to achieve long-term survival. Though the technical success rate (68.4%) and primary patency rate (36.8% at 6 months) of percutaneous mechanical trombectomy in our institution were comparable to other reports, more improved results were needed. Therefore, we have tried to develop a new salvage technique that is able to improve technical success rates and primary patency rates. Surgical revision at the time of thrombectomy, as directed by fistulography, has been demonstrated to improve patency rates [10, 11] . Combined surgical thrombectomy with endovascular treatment for salvage of thromobsed autogenous AVFs have been introduced and reported reasonable success rates (7 of 10, 70%) compared to others [12] .
To obtain the synergy effect of both surgical and endovascular treatment and to improve the technical success rate, hybrid surgery has been used for thrombosed autogenous AVFs salvage in our institution since June 2008.
Hybrid surgery is able to remove thrombus feasibly in the surgical fields and correct underlying causative lesions disclosed by the intra-operative fluoroscopy. As a consequence, hybrid surgery has shown much-improved technical success rates (92.5%), and higher primary patency rates than percutaneous mechanical thrombectomy in other reports [9] .
The most substantial contribution to a cost difference might have been due to significant differences in technical success or complication rates because the need for repeated procedures would likely overwhelm the moderate per-procedure costs, as could excess hospital stay and other costs of treatment complications. We demonstrated a significantly increased total cost for percutaneous mechanical thrombectomy as compared with hybrid surgery.
It is difficult to explain that the cost differences reflected the procedure itself because significantly different technical success rates were found between the two groups. The major components of this cost analysis were repeated or additional procedures and prolonged hospital stay.
Moreover, surgery is priced relatively low in Korea.
Hybrid surgery for treatment of thrombosed AVFs has several advantages. First, the thrombus could be removed more feasibly than percutaneous thrombectomy. Second, endovascular treatment could be performed in both proximal and distal vessels with a single skin incision and fistulotomy. Third, endovascular or surgical angioplasty was possible by the accurate detection of the stenosis site by fistulogram during surgery. Lastly, this operation setting permits easy conversion to surgical angioplasty.
Our study has some limitations, which include too small a number of case population to reach the relevant conclusions from these promising results, though autogenous AVF thrombosis is a relatively uncommon event than is graft thrombosis.
In conclusion, salvage procedures for thrombosed autogenous AVFs could be performed in an operation unit under the intra-operative fluoroscopy to define the cause of AVF thrombosis and to determine the method of appropriate revision. In this study, hybrid surgery showed higher a technical success rate and primary patency rate than those of percutaneous mechanical thrombectomy, thereby, avoiding the need for placement of a dialysis catheter.
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